BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness
- BD
FRANKLIN LAKES, N.J., Oct. 7, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity and domestic supply. Read more…
Related Reading
News / Digital Health / Regulatory Affairs
AdvaMed Releases Technical Performance and Safety Bulletin on “Remote Device Operations: Common Challenges and Mitigation Strategies”
October 2, 2025
WASHINGTON, D.C. – AdvaMed, the Medtech Association, recently published a technical performance and safety bulletin titled, “Remote Device Operations: Common Challenges and Mitigation Strategies” to help health care providers, device manufacturers, and IT teams navigate the complex landscape of remotely managing medical devices.
News / Global & Trade / Government & Legislative Affairs / Health Access / Supply Chain / Tariffs
AdvaMed Statement on Commerce Department Section 232 National Security Investigation
September 25, 2025
WASHINGTON—AdvaMed, the MedTech Association, released the following statement from President and CEO Scott Whitaker on the Administration’s announcement of its investigation under Section 232 of the Trade Expansion Act into whether the U.S.’s current level of medtech imports has national security implications:
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Thanks U.S. House Energy and Commerce Health Subcommittee for Highlighting the Need for Medicare Coverage of Breakthrough Medtech
September 18, 2025
WASHINGTON—AdvaMed, the medtech association, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft of breakthrough coverage legislation at a hearing, “Examining Policies to Enhance Seniors’ Access to Breakthrough Medical Technologies.”
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Welcomes Key U.S. House Committee Passage of Breakthrough Medtech Coverage Bill, Urges Addition of Diagnostic Tests
September 17, 2025
WASHINGTON—AdvaMed, the medtech association, today welcomed U.S. House of Representatives Committee on Ways and Means passage of legislation providing Medicare coverage of FDA-designated and authorized breakthrough medtech. AdvaMed also urged legislators to add diagnostic tests to the measure, the Ensuring Patient Access to Critical Breakthrough Products Act, H.R. 5343.
News / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
AdvaMed Welcomes CMS’ Rural Health Transformation Program
September 15, 2025
WASHINGTON—AdvaMed, the medtech association, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health care technologies that best suit their needs to improve health outcomes for rural Americans.
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Welcomes Bipartisan Bill to Support Patient Access to Laboratory Testing
September 12, 2025
WASHINGTON—AdvaMed, the medtech association, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act by Reps. Richard Hudson (R-N.C.), Scott Peters (D-Calif.), Gus Bilirakis (R-Fla.), Raja Krishnamoorthi (D-Ill.) and Brian Fitzpatrick (R-Pa.) and Sens. Thom Tillis (R-N.C.) and Raphael Warnock (D-Ga.)
Blog / Government & Legislative Affairs / The MedTech Conference
AdvaMed in Action: Building Alliances That Redefine Health Care at The MedTech Conference 2025
September 11, 2025
Bobby Patrick, AdvaMed’s SVP of Government & State Affairs and Alliance Development, on why #MTC25 is the can’t-miss moment to see the power of coalitions in action — where patients, policymakers, and innovators come together to share stories, shape policy, and spark alliances that last well beyond San Diego.
News / Government & Legislative Affairs / Regulatory Affairs
CDRH Director Tarver, Fellow FDA Leaders to Speak, Take Questions at The MedTech Conference
September 8, 2025
WASHINGTON, D.C.—AdvaMed, the medtech association, today announced a town hall featuring FDA Center for Devices and Radiological Health (CDRH) Director Michelle Tarver and fellow CDRH senior leaders at The MedTech Conference hosted by AdvaMed in San Diego in October. The town hall participants will update the audience on the center’s strategic direction and priorities and take questions.